Maria A. Font-Gomis
Health Research Institute Of The Balearic Islands
Palma, PM 07120, Spain
Palma, PM 07120, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Characterizing the V516M penicillin-binding protein 2 (PBP2) mutation causing zidebactam resistance in Pseudomonas aeruginosa.
Journal: Antimicrobial agents and chemotherapy
Published: June 15, 2026
Genetic and biochemical characterization of OXA-1054, a carbapenem-hydrolyzing class D β-lactamase conferring broad-spectrum β-lactam resistance in Pseudomonas aeruginosa.
Journal: Antimicrobial agents and chemotherapy
Published: May 29, 2026
PaREx: an open-source pipeline for the automated analysis of Pseudomonas aeruginosa resistomes from whole-genome sequences.
Journal: Antimicrobial agents and chemotherapy
Published: March 16, 2026
First nationwide survey on Pseudomonas aeruginosa in Bolivia: susceptibility profiles, resistome, and genomic epidemiology.
Journal: Antimicrobial agents and chemotherapy
Published: November 11, 2025
Contribution of mutational resistance mechanisms and acquired β-lactamases to cefiderocol/xeruborbactam susceptibility in Pseudomonas aeruginosa.
Journal: Antimicrobial agents and chemotherapy
Published: October 21, 2025
Functional and structural analyses of amino acid sequence variation in PDC β-lactamase reveal different mechanistic pathways toward cefiderocol resistance in Pseudomonas aeruginosa.
Journal: Antimicrobial agents and chemotherapy
Published: May 27, 2025
Spanish nationwide survey of Pseudomonas aeruginosa cefiderocol susceptibility and resistance mechanisms.
Journal: International journal of antimicrobial agents
Published: April 11, 2025
Mutant prevention concentrations and phenotypic and genomic profiling of first-step resistance mechanisms to classical and novel β-lactams in Pseudomonas aeruginosa.
Journal: Antimicrobial agents and chemotherapy
Published: March 11, 2025
Correction: Roson-Calero et al. Cyclic Peptide MV6, an Aminoglycoside Efficacy Enhancer Against Acinetobacter baumannii. Antibiotics 2024, 13, 1147.
Journal: Antibiotics (Basel, Switzerland)
Published: January 15, 2025
In vitro potentiation of tetracyclines in Pseudomonas aeruginosa by RW01, a new cyclic peptide.
Journal: Antimicrobial agents and chemotherapy
Published: December 23, 2024
Emerging resistance mechanisms to newer β-lactams in Pseudomonas aeruginosa.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: November 25, 2024
Cyclic Peptide MV6, an Aminoglycoside Efficacy Enhancer Against Acinetobacter baumannii.
Journal: Antibiotics (Basel, Switzerland)
Published: November 02, 2024
Last Updated: 09/26/2026